SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS)
IONS 73.14-1.2%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: emil who wrote (2023)6/9/1998 10:17:00 AM
From: TomOrt  Read Replies (1) of 4676
 
emil;
This sounds like a good deal for ISIP.
Here's what D.J. had to say....

June 9, 1998

Isis Pharma, Merck In Hepatitis C Research Pact
Dow Jones Newswires

CARLSBAD, Calif. -- Isis Pharmaceuticals Inc. (ISIP) and Merck & Co. (MRK) formed a three-year research collaboration to discover drug candidates for treating patients with hepatitis C.

In a press release Tuesday, Isis said it will receive significant annual research support as well as a one-time technology access fee.

The company also will receive milestone payments as compounds arising from the collaboration proceed through clinical development and royalties from product sales.

Under the terms of the collaboration, the companies' chemists will design, synthesize and evaluate small molecules that Merck will screen in its enzymatic assays to identify hepatitis C replication inhibitors.

Merck has the right to commercialize drugs from the collaboration, while Isis retains the rights to use the technology developed in collaboration with its antisense program.

Merck is a research and development pharmaceutical company.

Isis discovers and devlops human therapeutic compounds.

--------------------------------------------------------------------------------

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News